Immune-Modulating Drugs and Hypomethylating Agents to Prevent or Treat Relapse after Allogeneic Stem Cell Transplantation
Open Access
- 24 September 2013
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 20 (2), 168-172
- https://doi.org/10.1016/j.bbmt.2013.09.009
Abstract
No abstract availableKeywords
Funding Information
- Celgene
This publication has 50 references indexed in Scilit:
- A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2011
- Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensPublished by American Society of Hematology ,2010
- Understanding and harnessing the graft‐versus‐leukaemia effectBritish Journal of Haematology, 2008
- Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI aloneBlood, 2007
- Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cellsBlood, 2004
- Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaProceedings of the National Academy of Sciences of the United States of America, 2003
- Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow TransplantBlood, 1998
- CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantationBlood, 1995
- Interferon-α And Donor Buffy Coat Transfusions For Treatment Of Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow TransplantationTransplantation, 1993